Back to
ROYAL BANK OF CANADA
EVLOShowing 0 of 3 quarters
Position history for
ROYAL BANK OF CANADA's holdings in EVELO BIOSCIENCES INC
No. Royal Bank of Canada exited its EVLO (Evelo Biosciences) position in Q4 2023. Its Q3 2023 13F listed 505 shares worth $2,000. Royal Bank of Canada first reported EVLO in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EVLO: FMR LLC, Alyeska Investment Group, L.P., STATE OF MICHIGAN RETIREMENT SYSTEM